Marginal Zone Lymphoma (MZL)

Also known as: MZL / Marginal Zone Lymphomas / Marginal Zone Lymphoma(MZL) / Lymphoma, Marginal Zone / Marginal Zone Lymphoma / Marginal Lymphoma / Marginal zone lymphoma -RETIRED- / Marginal zone B-cell lymphoma (morphologic abnormality) / Marginal zone lymphoma (disorder)

Drug	Drug Name	Drug Description
DB09053	Ibrutinib	An antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia.
DB00480	Lenalidomide	A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome.

Drug	Drug Name	Target	Type
DB09053	Ibrutinib	Tyrosine-protein kinase BTK	target
DB09053	Ibrutinib	Cytochrome P450 3A4	enzyme
DB09053	Ibrutinib	Cytochrome P450 3A5	enzyme
DB09053	Ibrutinib	Serum albumin	carrier
DB09053	Ibrutinib	alpha1-acid glycoprotein	carrier
DB09053	Ibrutinib	Cytochrome P450 2D6	enzyme
DB00480	Lenalidomide	Prostaglandin G/H synthase 2	target
DB00480	Lenalidomide	Tumor necrosis factor ligand superfamily member 11	target
DB00480	Lenalidomide	Cadherin-5	target
DB00480	Lenalidomide	Protein cereblon	target
DB00480	Lenalidomide	P-glycoprotein 1	transporter

Drug	Drug Name	Phase	Status	Count
DB10319	Streptococcus pneumoniae type 1 capsular polysaccharide antigen	0	Completed	1
DB10329	Streptococcus pneumoniae type 10a capsular polysaccharide antigen	0	Completed	1
DB10330	Streptococcus pneumoniae type 11a capsular polysaccharide antigen	0	Completed	1
DB10331	Streptococcus pneumoniae type 12f capsular polysaccharide antigen	0	Completed	1
DB10332	Streptococcus pneumoniae type 14 capsular polysaccharide antigen	0	Completed	1
DB10333	Streptococcus pneumoniae type 15b capsular polysaccharide antigen	0	Completed	1
DB10334	Streptococcus pneumoniae type 17f capsular polysaccharide antigen	0	Completed	1
DB10335	Streptococcus pneumoniae type 18c capsular polysaccharide antigen	0	Completed	1
DB10337	Streptococcus pneumoniae type 19a capsular polysaccharide antigen	0	Completed	1
DB10336	Streptococcus pneumoniae type 19f capsular polysaccharide antigen	0	Completed	1
DB10320	Streptococcus pneumoniae type 2 capsular polysaccharide antigen	0	Completed	1
DB10338	Streptococcus pneumoniae type 20 capsular polysaccharide antigen	0	Completed	1
DB10339	Streptococcus pneumoniae type 22f capsular polysaccharide antigen	0	Completed	1
DB10340	Streptococcus pneumoniae type 23f capsular polysaccharide antigen	0	Completed	1
DB10321	Streptococcus pneumoniae type 3 capsular polysaccharide antigen	0	Completed	1
DB10341	Streptococcus pneumoniae type 33f capsular polysaccharide antigen	0	Completed	1
DB10322	Streptococcus pneumoniae type 4 capsular polysaccharide antigen	0	Completed	1
DB10323	Streptococcus pneumoniae type 5 capsular polysaccharide antigen	0	Completed	1
DB10324	Streptococcus pneumoniae type 6b capsular polysaccharide antigen	0	Completed	1
DB10325	Streptococcus pneumoniae type 7f capsular polysaccharide antigen	0	Completed	1
DB10326	Streptococcus pneumoniae type 8 capsular polysaccharide antigen	0	Completed	1
DB10327	Streptococcus pneumoniae type 9n capsular polysaccharide antigen	0	Completed	1
DB10328	Streptococcus pneumoniae type 9v capsular polysaccharide antigen	0	Completed	1
DB09312	Antilymphocyte immunoglobulin (horse)	1	Completed	1
DB00098	Antithymocyte immunoglobulin (rabbit)	1	Completed	1
DB17387	BR101801	1	Recruiting	1
DB06769	Bendamustine	1	Completed	1
DB01413	Cefepime	1	Completed	1
DB12483	Copanlisib	1	Recruiting	1
DB00531	Cyclophosphamide	1	Recruiting	2
DB00099	Filgrastim	1	Completed	1
DB00196	Fluconazole	1	Completed	1
DB01073	Fludarabine	1	Completed	1
DB01073	Fludarabine	1	Recruiting	2
DB09053	Ibrutinib	1	Withdrawn	1
DB09054	Idelalisib	1	Completed	1
DB00480	Lenalidomide	1	Terminated	1
DB16222	Loncastuximab tesirine	1	Completed	1
DB16225	Magrolimab	1	Recruiting	1
DB16620	Methopterin	1	Completed	1
DB00563	Methotrexate	1	Completed	1
DB09035	Nivolumab	1	Recruiting	1
DB08935	Obinutuzumab	1	Recruiting	2
DB00338	Omeprazole	1	Completed	1
DB09037	Pembrolizumab	1	Completed	1
DB00912	Repaglinide	1	Completed	1
DB00073	Rituximab	1	Completed	1
DB00864	Tacrolimus	1	Completed	1
DB12887	Tazemetostat	1	Completed	2
DB11850	Ublituximab	1	Recruiting	1
DB11850	Ublituximab	1	Terminated	1
DB11581	Venetoclax	1	Recruiting	2
DB15157	Voruciclib	1	Recruiting	1
DB15773	anti-OX40 antibody BMS 986178	1	Active Not Recruiting	1
DB11703	Acalabrutinib	1 / 2	Active Not Recruiting	1
DB06769	Bendamustine	1 / 2	Recruiting	1
DB16741	Bortezomib D-mannitol	1 / 2	Withdrawn	1
DB00631	Clofarabine	1 / 2	Active Not Recruiting	1
DB06189	Clofarabine	1 / 2	Active Not Recruiting	1
DB00531	Cyclophosphamide	1 / 2	Completed	1
DB00531	Cyclophosphamide	1 / 2	Recruiting	2
DB00997	Doxorubicin	1 / 2	Completed	1
DB00997	Doxorubicin	1 / 2	Recruiting	1
DB12121	Entospletinib	1 / 2	Completed	1
DB16672	Epcoritamab	1 / 2	Recruiting	3
DB00441	Gemcitabine	1 / 2	Recruiting	1
DB09053	Ibrutinib	1 / 2	Active Not Recruiting	1
DB09053	Ibrutinib	1 / 2	Recruiting	1
DB09054	Idelalisib	1 / 2	Completed	1
DB00480	Lenalidomide	1 / 2	Completed	1
DB00480	Lenalidomide	1 / 2	Recruiting	2
DB08935	Obinutuzumab	1 / 2	Completed	1
DB00526	Oxaliplatin	1 / 2	Recruiting	1
DB09037	Pembrolizumab	1 / 2	Active Not Recruiting	1
DB00552	Pentostatin	1 / 2	Withdrawn	1
DB17472	Pirtobrutinib	1 / 2	Recruiting	1
DB12240	Polatuzumab vedotin	1 / 2	Recruiting	1
DB00635	Prednisone	1 / 2	Completed	1
DB00635	Prednisone	1 / 2	Recruiting	1
DB00073	Rituximab	1 / 2	Completed	1
DB00073	Rituximab	1 / 2	Recruiting	3
DB00073	Rituximab	1 / 2	Withdrawn	1
DB17130	Spanlecortemlocel	1 / 2	Completed	1
DB14922	Tislelizumab	1 / 2	Recruiting	1
DB11850	Ublituximab	1 / 2	Completed	1
DB16657	Vecabrutinib	1 / 2	Terminated	1
DB11581	Venetoclax	1 / 2	Recruiting	1
DB00541	Vincristine	1 / 2	Completed	1
DB00541	Vincristine	1 / 2	Recruiting	1
DB15035	Zanubrutinib	1 / 2	Recruiting	1
DB11703	Acalabrutinib	2	Recruiting	2
DB11703	Acalabrutinib	2	Terminated	1
DB09312	Antilymphocyte immunoglobulin (horse)	2	Terminated	1
DB00098	Antithymocyte immunoglobulin (rabbit)	2	Terminated	1
DB11595	Atezolizumab	2	Completed	1
DB13915	Axicabtagene ciloleucel	2	Active Not Recruiting	1
DB00928	Azacitidine	2	Terminated	1
DB06769	Bendamustine	2	Withdrawn	1
DB00188	Bortezomib	2	Recruiting	1
DB00188	Bortezomib	2	Terminated	1
DB16741	Bortezomib D-mannitol	2	Completed	1
DB16741	Bortezomib D-mannitol	2	Terminated	1
DB08870	Brentuximab vedotin	2	Withdrawn	1
DB16382	Brentuximab vedotin	2	Withdrawn	1
DB01008	Busulfan	2	Active Not Recruiting	1
DB00958	Carboplatin	2	Terminated	1
DB08889	Carfilzomib	2	Terminated	1
DB12483	Copanlisib	2	Recruiting	1
DB00531	Cyclophosphamide	2	Active Not Recruiting	3
DB00531	Cyclophosphamide	2	Recruiting	1
DB00091	Cyclosporine	2	Active Not Recruiting	1
DB06210	Eltrombopag	2	Terminated	1
DB00445	Epirubicin	2	Recruiting	1
DB00773	Etoposide	2	Terminated	1
DB01073	Fludarabine	2	Active Not Recruiting	3
DB00441	Gemcitabine	2	Terminated	1
DB00078	Ibritumomab tiuxetan	2	Completed	1
DB09053	Ibrutinib	2	Completed	1
DB09053	Ibrutinib	2	Recruiting	1
DB09053	Ibrutinib	2	Withdrawn	1
DB09054	Idelalisib	2	Active Not Recruiting	1
DB09054	Idelalisib	2	Completed	1
DB01181	Ifosfamide	2	Terminated	1
DB05003	Imexon	2	Completed	1
DB15244	Iopofosine I-131	2	Recruiting	1
DB09570	Ixazomib	2	Active Not Recruiting	1
DB00480	Lenalidomide	2	Recruiting	1
DB00480	Lenalidomide	2	Terminated	1
DB16222	Loncastuximab tesirine	2	Recruiting	1
DB01042	Melphalan	2	Active Not Recruiting	1
DB15434	Mosunetuzumab	2	Recruiting	2
DB00075	Muromonab	2	Recruiting	1
DB00688	Mycophenolate mofetil	2	Active Not Recruiting	2
DB08935	Obinutuzumab	2	Active Not Recruiting	1
DB08935	Obinutuzumab	2	Completed	1
DB08935	Obinutuzumab	2	Recruiting	2
DB06650	Ofatumumab	2	Completed	1
DB09037	Pembrolizumab	2	Active Not Recruiting	1
DB12240	Polatuzumab vedotin	2	Recruiting	1
DB00635	Prednisone	2	Recruiting	1
DB00073	Rituximab	2	Active Not Recruiting	1
DB00073	Rituximab	2	Completed	3
DB00073	Rituximab	2	Recruiting	5
DB00073	Rituximab	2	Terminated	2
DB00073	Rituximab	2	Withdrawn	1
DB00864	Tacrolimus	2	Active Not Recruiting	1
DB00864	Tacrolimus	2	Terminated	1
DB15044	Tafasitamab	2	Recruiting	1
DB04572	Thiotepa	2	Active Not Recruiting	1
DB00135	Tyrosine	2	Recruiting	1
DB11850	Ublituximab	2	Suspended	1
DB14989	Umbralisib	2	Recruiting	1
DB14989	Umbralisib	2	Suspended	1
DB11581	Venetoclax	2	Completed	1
DB11581	Venetoclax	2	Recruiting	1
DB02546	Vorinostat	2	Terminated	1
DB15035	Zanubrutinib	2	Completed	2
DB15035	Zanubrutinib	2	Recruiting	1
DB06769	Bendamustine	2 / 3	Terminated	1
DB11850	Ublituximab	2 / 3	Terminated	1
DB14989	Umbralisib	2 / 3	Terminated	1
DB06769	Bendamustine	3	Active Not Recruiting	1
DB06769	Bendamustine	3	Completed	1
DB06769	Bendamustine	3	Withdrawn	1
DB00531	Cyclophosphamide	3	Active Not Recruiting	1
DB00531	Cyclophosphamide	3	Completed	2
DB00997	Doxorubicin	3	Completed	2
DB11952	Duvelisib	3	Withdrawn	1
DB09053	Ibrutinib	3	Recruiting	1
DB00480	Lenalidomide	3	Recruiting	2
DB08935	Obinutuzumab	3	Recruiting	1
DB08935	Obinutuzumab	3	Withdrawn	1
DB14867	Parsaclisib	3	Withdrawn	1
DB00635	Prednisone	3	Active Not Recruiting	1
DB00635	Prednisone	3	Completed	2
DB00073	Rituximab	3	Active Not Recruiting	3
DB00073	Rituximab	3	Completed	2
DB00073	Rituximab	3	Recruiting	3
DB00073	Rituximab	3	Withdrawn	2
DB15044	Tafasitamab	3	Recruiting	1
DB00541	Vincristine	3	Active Not Recruiting	1
DB00541	Vincristine	3	Completed	2
DB15035	Zanubrutinib	3	Recruiting	1
DB00188	Bortezomib	Not Available	Terminated	1
DB16741	Bortezomib D-mannitol	Not Available	Terminated	1
DB00531	Cyclophosphamide	Not Available	Terminated	1
DB09037	Pembrolizumab	Not Available	Recruiting	1
DB00635	Prednisone	Not Available	Terminated	1
DB00073	Rituximab	Not Available	Recruiting	1
DB00073	Rituximab	Not Available	Terminated	1